Is Enzo Biochem Stock a Good Investment?

Enzo Biochem Investment Advice

  ENZ
To provide specific investment advice or recommendations on Enzo Biochem stock, we recommend investors consider the following general factors when evaluating Enzo Biochem. This will help you to make an informed decision on whether to include Enzo Biochem in one of your diversified portfolios:
  • Examine Enzo Biochem's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Enzo Biochem's leadership team and their track record. Good management can help Enzo Biochem navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Enzo Biochem's business and its evolving consumer preferences.
  • Compare Enzo Biochem's performance and market position to its competitors. Analyze how Enzo Biochem is positioned in terms of product offerings, innovation, and market share.
  • Check if Enzo Biochem pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Enzo Biochem's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Enzo Biochem stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Enzo Biochem is a good investment.
 
Sell
 
Buy
Strong Sell
We provide trade advice to complement the prevailing expert consensus on Enzo Biochem. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Enzo Biochem is not overpriced, please confirm all Enzo Biochem fundamentals, including its net income and the relationship between the book value per share and current liabilities . As Enzo Biochem appears to be a penny stock we also advise to verify its price to earning numbers.

Market Performance

Very WeakDetails

Volatility

Abnormally volatileDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

Below AverageDetails

Economic Sensitivity

Follows the market closelyDetails

Investor Sentiment

InterestedDetails

Analyst Consensus

Strong SellDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

UnavailableDetails

Examine Enzo Biochem Stock

Researching Enzo Biochem's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 22.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.72. Some equities with similar Price to Book (P/B) outperform the market in the long run. Enzo Biochem recorded a loss per share of 0.15. The entity last dividend was issued on the 15th of November 2024. The firm had 105:100 split on the 21st of October 2004.
To determine if Enzo Biochem is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Enzo Biochem's research are outlined below:
Enzo Biochem generated a negative expected return over the last 90 days
Enzo Biochem has some characteristics of a very speculative penny stock
Enzo Biochem has high historical volatility and very poor performance
The company reported the last year's revenue of 31.91 M. Reported Net Loss for the year was (26.08 M) with profit before taxes, overhead, and interest of 14.63 M.
Enzo Biochem has about 82.37 M in cash with (26.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Roughly 22.0% of the company shares are held by company insiders
On 2nd of December 2024 Enzo Biochem paid $ 0.1 per share dividend to its current shareholders
Latest headline from investing.com: Acquisition by Couchman Jonathan of 142897 shares of Enzo Biochem subject to Rule 16b-3
Enzo Biochem uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Enzo Biochem. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Enzo Biochem's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
18th of March 2024
Upcoming Quarterly Report
View
31st of January 2024
Next Fiscal Quarter End
View
Earnings surprises can significantly impact Enzo Biochem's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Enzo Biochem's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2016-03-09
2016-01-31-0.06-0.07-0.0116 
2015-06-09
2015-04-30-0.06-0.07-0.0116 
2014-10-09
2014-07-31-0.07-0.060.0114 
2013-12-10
2013-10-31-0.06-0.07-0.0116 
2008-10-14
2008-07-31-0.06-0.07-0.0116 
2008-06-09
2008-04-30-0.07-0.060.0114 
2001-03-15
2001-01-310.060.05-0.0116 
2000-12-14
2000-10-310.060.05-0.0116 

Know Enzo Biochem's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Enzo Biochem is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Enzo Biochem backward and forwards among themselves. Enzo Biochem's institutional investor refers to the entity that pools money to purchase Enzo Biochem's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Nierenberg Investment Management Co2024-09-30
88.6 K
Morgan Stanley - Brokerage Accounts2024-09-30
71.9 K
Northern Trust Corp2024-09-30
67.2 K
Squarepoint Ops Llc2024-09-30
56.6 K
Lazard Asset Management Llc2024-09-30
50.5 K
T. Rowe Price Associates, Inc.2024-09-30
44.8 K
Xtx Topco Ltd2024-09-30
34.4 K
Citadel Advisors Llc2024-09-30
26.6 K
Millennium Management Llc2024-09-30
25.7 K
Harbert Fund Advisors Inc2024-09-30
5.2 M
Renaissance Technologies Corp2024-09-30
2.5 M
Note, although Enzo Biochem's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Enzo Biochem's market capitalization trends

The company currently falls under 'Micro-Cap' category with a total capitalization of 35.29 M.

Market Cap

49.61 Million

Enzo Biochem's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(0.35)(0.33)
Return On Capital Employed(0.19)(0.18)
Return On Assets(0.35)(0.33)
Return On Equity(0.42)(0.44)
The company has Net Profit Margin of (0.82) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.39) %, which entails that for every $100 of revenue, it lost $0.39.
Determining Enzo Biochem's profitability involves analyzing its financial statements and using various financial metrics to determine if Enzo Biochem is a good buy. For example, gross profit margin measures Enzo Biochem's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Enzo Biochem's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Enzo Biochem's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Enzo Biochem. Check Enzo Biochem's Beneish M Score to see the likelihood of Enzo Biochem's management manipulating its earnings.

Evaluate Enzo Biochem's management efficiency

Enzo Biochem has Return on Asset of (0.0744) % which means that on every $100 spent on assets, it lost $0.0744. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1459) %, meaning that it generated no profit with money invested by stockholders. Enzo Biochem's management efficiency ratios could be used to measure how well Enzo Biochem manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.33 in 2025. Return On Capital Employed is likely to rise to -0.18 in 2025. At this time, Enzo Biochem's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 32 M in 2025, whereas Non Currrent Assets Other are likely to drop slightly above 453.1 K in 2025.
Last ReportedProjected for Next Year
Book Value Per Share 1.27  2.20 
Tangible Book Value Per Share 0.99  1.26 
Enterprise Value Over EBITDA(1.26)(1.20)
Price Book Value Ratio 1.19  1.13 
Enterprise Value Multiple(1.26)(1.20)
Price Fair Value 1.19  1.13 
Enterprise Value8.2 M7.8 M
Leadership effectiveness at Enzo Biochem is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Dividend Yield
0.396
Forward Dividend Yield
0.396
Forward Dividend Rate
0.4
Beta
0.729

Basic technical analysis of Enzo Stock

As of the 22nd of January, Enzo Biochem shows the Variance of 19.91, mean deviation of 2.21, and Standard Deviation of 4.46. Enzo Biochem technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Enzo Biochem's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Enzo Biochem insiders, such as employees or executives, is commonly permitted as long as it does not rely on Enzo Biochem's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Enzo Biochem insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Enzo Biochem's Outstanding Corporate Bonds

Enzo Biochem issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Enzo Biochem uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Enzo bonds can be classified according to their maturity, which is the date when Enzo Biochem has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Enzo Biochem's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Enzo Biochem's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Enzo Biochem's intraday indicators

Enzo Biochem intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Enzo Biochem stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Enzo Biochem time-series forecasting models is one of many Enzo Biochem's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Enzo Biochem's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Enzo Stock media impact

Far too much social signal, news, headlines, and media speculation about Enzo Biochem that are available to investors today. That information is available publicly through Enzo media outlets and privately through word of mouth or via Enzo internal channels. However, regardless of the origin, that massive amount of Enzo data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Enzo Biochem news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Enzo Biochem relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Enzo Biochem's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Enzo Biochem alpha.

Enzo Biochem Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Enzo Biochem can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Enzo Biochem Corporate Directors

Mary TagliaferriLead Independent DirectorProfile
Dov PerlyskyLead Independent DirectorProfile
Ian WaltersIndependent DirectorProfile
Bruce HannaIndependent DirectorProfile

Additional Tools for Enzo Stock Analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.